rs3744161

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005993.5(TBCD):​c.1319-43G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 1,609,494 control chromosomes in the GnomAD database, including 258,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21529 hom., cov: 33)
Exomes 𝑓: 0.57 ( 237002 hom. )

Consequence

TBCD
NM_005993.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.484

Publications

10 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-82870181-G-A is Benign according to our data. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-82870181-G-A is described in CliVar as Benign. Clinvar id is 1265397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.69 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBCDNM_005993.5 linkc.1319-43G>A intron_variant Intron 13 of 38 ENST00000355528.9 NP_005984.3 Q9BTW9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBCDENST00000355528.9 linkc.1319-43G>A intron_variant Intron 13 of 38 1 NM_005993.5 ENSP00000347719.4 Q9BTW9-1

Frequencies

GnomAD3 genomes
AF:
0.522
AC:
79274
AN:
151930
Hom.:
21511
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.364
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.512
Gnomad EAS
AF:
0.710
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.578
Gnomad OTH
AF:
0.535
GnomAD2 exomes
AF:
0.563
AC:
137718
AN:
244402
AF XY:
0.558
show subpopulations
Gnomad AFR exome
AF:
0.355
Gnomad AMR exome
AF:
0.628
Gnomad ASJ exome
AF:
0.517
Gnomad EAS exome
AF:
0.727
Gnomad FIN exome
AF:
0.595
Gnomad NFE exome
AF:
0.573
Gnomad OTH exome
AF:
0.556
GnomAD4 exome
AF:
0.567
AC:
826919
AN:
1457446
Hom.:
237002
Cov.:
40
AF XY:
0.565
AC XY:
409692
AN XY:
725248
show subpopulations
African (AFR)
AF:
0.352
AC:
11768
AN:
33424
American (AMR)
AF:
0.617
AC:
27550
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
0.516
AC:
13467
AN:
26104
East Asian (EAS)
AF:
0.741
AC:
29414
AN:
39682
South Asian (SAS)
AF:
0.464
AC:
40033
AN:
86196
European-Finnish (FIN)
AF:
0.592
AC:
29537
AN:
49918
Middle Eastern (MID)
AF:
0.463
AC:
2669
AN:
5764
European-Non Finnish (NFE)
AF:
0.575
AC:
639174
AN:
1111408
Other (OTH)
AF:
0.552
AC:
33307
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
19642
39284
58926
78568
98210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17650
35300
52950
70600
88250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
79335
AN:
152048
Hom.:
21529
Cov.:
33
AF XY:
0.524
AC XY:
38975
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.364
AC:
15097
AN:
41476
American (AMR)
AF:
0.587
AC:
8972
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
1777
AN:
3470
East Asian (EAS)
AF:
0.710
AC:
3657
AN:
5154
South Asian (SAS)
AF:
0.465
AC:
2239
AN:
4820
European-Finnish (FIN)
AF:
0.602
AC:
6357
AN:
10564
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.578
AC:
39280
AN:
67972
Other (OTH)
AF:
0.539
AC:
1133
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1885
3769
5654
7538
9423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.518
Hom.:
5942
Bravo
AF:
0.516
Asia WGS
AF:
0.542
AC:
1887
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.4
DANN
Benign
0.75
PhyloP100
-0.48
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744161; hg19: chr17-80828057; COSMIC: COSV62801426; API